The race to fuel the nuclear future | The Next Big Thing

Isotope enrichment serves as a critical foundation for modern advancements in cancer treatment, semiconductor manufacturing, and next-generation nuclear energy. Western infrastructure currently faces a significant supply deficit for these essential materials, prompting companies like ASP Isotopes and its subsidiary, Quantum Leap Energy, to develop proprietary enrichment technologies. Paul Mann, CEO of ASP Isotopes, and Dr. Ryno Pretorius, CEO of Quantum Leap Energy, emphasize that scaling these operations is vital to meeting the surging power demands of global data centers. New reactor designs, such as small modular reactors, offer inherently safe, autonomous alternatives to legacy systems, provided the nuclear fuel cycle—including conversion, enrichment, and deconversion—is robustly supported. Addressing these supply chain gaps requires shifting focus toward hard tech, leveraging historical expertise, and securing long-term partnerships to ensure a reliable, sustainable energy future.